NCT06446648View on ClinicalTrials.gov

Impact of Intraoperative ICG on Functional Outc in RARP

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 12, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2028

Conditions
Prostate Adenocarcinoma
Interventions
DRUG

ICG

Administer an IV ICG injection intraoperatively, using the optimal dosage and timing defined in the second phase of the study. Utilize the newly developed 3D vascular map for visualization of the arteries before and after prostate resection.

Trial Locations (1)

92868

RECRUITING

Chao Family Comprehensive Cancer Center University of California, Irvine, Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER